HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Opportunistic infections in patients under highly concentrated antiretroviral therapy].

AbstractUNLABELLED:
VARIABLE RESULTS: The restoration of immunological competence following Highly Active AntiRetroviral Therapy (HAART) has led to promising results concerning cytomegalovirus viremia, atypical mycobacterium infections, and survival in patients treated for non-Hodgkin's lymphomas. The beneficial effect of introducing antiproteases is less clear for other opportunistic infections such as tuberculosis and pyogenic infections.
PROPHYLAXIS:
In patients with a CD4 count above 240/mm3, it would appear possible to stop primary prophylaxis against Pneumocystis carinii and toxoplasmosis.
AuthorsM Jouan
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 27 Suppl 5 Pg. 21-2 (Dec 1998) ISSN: 0755-4982 [Print] France
Vernacular TitleInfections opportunistes sous traitements antirétroviraux combinés.
PMID9879332 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-HIV Agents
  • Antiviral Agents
Topics
  • AIDS-Related Opportunistic Infections (chemically induced)
  • Anti-HIV Agents (administration & dosage, therapeutic use)
  • Antiviral Agents (administration & dosage, therapeutic use)
  • Cytomegalovirus Infections (drug therapy, immunology, virology)
  • Drug Therapy, Combination
  • Humans
  • Immunocompetence (drug effects)
  • Lymphoma, Non-Hodgkin (drug therapy, immunology, virology)
  • Mycobacterium Infections, Nontuberculous (drug therapy, immunology)
  • Retroviridae (drug effects)
  • Retroviridae Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: